# Email Draft: Russ Altman

**Status:** READY TO SEND

**Email:** russ.altman@stanford.edu (verified via Stanford)

---

## Recipient Research

| Field | Details |
|-------|---------|
| **Name** | Russ Altman |
| **Position** | Professor of Bioengineering, Genetics, Medicine, Stanford |
| **Key Work** | PharmGKB, pharmacogenomics, variant interpretation |
| **Recent Focus** | Clinical significance of genetic variants |
| **Lab** | helix.stanford.edu |

---

## EMAIL

**To:** russ.altman@stanford.edu

**Subject:** VUS stability triage - useful for PharmGKB workflow?

---

Prof. Altman,

PharmGKB's variant annotation work involves triaging VUS. I'm wondering if stability prediction could help prioritize which variants to investigate further.

We've built a sequence-only stability predictor (œÅ=0.58 on S669 subset (N=52)) that's fast enough to screen large VUS lists. The idea: flag variants likely to affect protein stability for closer attention.

Questions:
1. Would predicted stability impact be useful as a VUS triage feature?
2. What confidence threshold would be needed for clinical utility?

Trying to understand if this fits into pharmacogenomics workflows.

Best,
Ivan Weiss Van Der Pol
Jonathan Verdun
Kyrian Weiss Van Der Pol
AI Whisperers | CONACYT Paraguay
github.com/Ai-Whisperers/ternary-vaes-bioinformatics

---

## Notes

- **Word count:** 100
- **Why this works:** Connects to his actual workflow (VUS triage), asks practical questions
- **Tone:** Clinical application focus

---

*Last Updated: 2026-01-26*
